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Abstract
Bartonella species are blood-borne, re-emerging organisms, capable of causing prolonged
infection with diverse disease manifestations, from asymptomatic bacteremia to chronic de-
bilitating disease and death. This pathogen can survive for over a month in stored blood.
However, its prevalence among blood donors is unknown, and screening of blood supplies
for this pathogen is not routinely performed. We investigated Bartonella spp. prevalence in
500 blood donors from Campinas, Brazil, based on a cross-sectional design. Blood samples
were inoculated into an enrichment liquid growth medium and sub-inoculated onto blood
agar. Liquid culture samples and Gram-negative isolates were tested using a genus specific
ITS PCR with amplicons sequenced for species identification. Bartonella henselae and Bar-
tonella quintana antibodies were assayed by indirect immunofluorescence. B. henselae
was isolated from six donors (1.2%). Sixteen donors (3.2%) were Bartonella-PCR positive
after culture in liquid or on solid media, with 15 donors infected with B. henselae and one
donor infected with Bartonella clarridgeiae. Antibodies against B. henselae or B. quintana
were found in 16% and 32% of 500 blood donors, respectively. Serology was not associated
with infection, with only three of 16 Bartonella-infected subjects seropositive for B. henselae
or B. quintana. Bartonella DNA was present in the bloodstream of approximately one out of
30 donors from a major blood bank in South America. Negative serology does not rule out
Bartonella spp. infection in healthy subjects. Using a combination of liquid and solid cul-
tures, PCR, and DNA sequencing, this study documents for the first time that Bartonella
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spp. bacteremia occurs in asymptomatic blood donors. Our findings support further evalua-
tion of Bartonella spp. transmission which can occur through blood transfusions.
Author Summary
Bartonella is a genus of small bacteria with worldwide distribution, transmitted by blood-
sucking insects, and is capable of causing disease in humans and animals. Some of the clin-
ical presentations of Bartonella spp., such as cat scratch disease, trench fever, and bacillary
angiomatosis are well documented; however, novel presentations have been described in
the last two decades, ranging from cyclic flu-like syndrome to neurologic disease and life-
threatening endocarditis. Asymptomatic human infection is possible and accidental blood
transmission has been reported. Bacterium isolation is very difficult because they grow
slowly and require special culture media and procedures. Serology testing poorly predicts
active Bartonella infection, except in infection of cardiac valves. Therefore, diagnosis is
generally challenging. However, when molecular detection techniques are coupled with
special culture protocols, enhanced sensitivity and specificity can be achieved. We investi-
gated Bartonella spp. infection prevalence in a large blood donor population and con-
firmed bacteremia in 1.2% of the subjects. Bloodstream infection was detected with at least
three different molecular methods in 3.2% of donors. These results indicate that Bartonella
is a genus of importance for transfusion medicine.
Introduction
Bartonella, a genus of fastidious bacteria with worldwide distribution, is responsible for persis-
tent infections in animals and humans [1]. Bartonella spp. are considered neglected zoonotic
pathogens, presumed to be transmitted to humans by a variety of arthropod vectors including
sandflies, body lice, fleas, ticks, and keds [1,2]. During the past several years, the spectrum of
clinical manifestations associated with bartonellosis, a term that now encompasses infection
with any Bartonella spp., has widened substantially [3]. In humans, Bartonella spp. are known
causative agents of Peruvian bartonellosis, cat scratch disease, trench fever, and bacillary angio-
matosis [1]. However, more recent studies have documented bloodstream infections in patients
with cardiovascular, neurological, and rheumatologic disease manifestations [4,5]. With the ex-
ception of localized lymphadenopathy or blood-culture-negative endocarditis, physicians rare-
ly consider Bartonella sp. infection among differential diagnoses [6].
Bartonella spp. are able to infect and survive inside erythrocytes [7], resulting in a long-last-
ing intraerythrocytic and presumably intraendothelial infection, which can be associated with a
relapsing pattern of bacteremia [8]. In vitro, these bacteria have been shown to invade, multiply
within, and persist for the lifetime of the infected host cell [9,10]. Prolonged bacteremia allows
greater opportunity for arthropod vector and other modes of transmission to occur between
hosts. Although at least fifteen Bartonella spp. have been associated with human infections,
B. henselae is the most frequent species identified from humans, as well as from companion an-
imals such as cats and dogs [1,9]. There is no single gold standard methodology to diagnose
bartonellosis and multi-step platforms are necessary to decrease false-negative test results [1].
Culture in liquid and solid media, multiple PCR reactions and serology have been used togeth-
er to improve the diagnostic sensitivity [8,11].
Bartonella spp. Bacteremia in Blood Donors
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Previous studies by our group using transmission electron microscopy and culture isolation
have documented the ability of B. henselae to survive in stored blood for 35 days, suggesting
the potential for transfusion-associated transmission [12]. We also documented B. henselae ad-
hered to human erythrocytes 10 hours after inoculation of the bacteria into blood and intraery-
throcytic infection after 72 hours [13]. These results suggested a potentially important role for
Bartonella sp. in transfusion medicine, particularly as blood transfusion infection has been doc-
umented in cats [14] and needle stick transmission of Bartonella sp. has also been reported in
two veterinarians [15,16]. Since the presence of selected Bartonella spp. was previously docu-
mented in blood samples of asymptomatic subjects [17–20], we hypothesized that bloodstream
infection with Bartonella sp. occurs in blood donors at the time of donation. The objective of
this study was to determine the seroprevalence and frequency of bacteremia caused by Barto-
nella spp. in a large asymptomatic blood donor population in Campinas, São Paulo State,
Brazil.
Methods
Study design and participants
A cross-sectional study was conducted at the UNICAMP Blood Bank (HEMOCENTRO),
which serves a geographic region with an estimated population of 6.4 million people in the São
Paulo state, Brazil. Healthy blood donors were randomly recruited from November 19th to De-
cember 23rd 2009, at the time of their voluntary blood donation. Sample size was estimated in
473 subjects to allow for estimation of at least 5% prevalence of bloodstream infection with
Bartonella spp. in blood donors, with a desired precision of 5% given a 95% confidence limit
and a design effect of 1. Therefore, with possible attrition, we enrolled 500 donors. This study
was approved by the Research Ethics Committee of the University of Campinas (UNICAMP),
Brazil (CEP122/2005). An informed written consent, approved by the UNICAMP Research
Ethics Committee, was obtained from each participant. Donor selection, blood collection, and
infectious disease screening were performed in accordance with current international stan-
dards [21,22]. Following aseptic preparation of the venipuncture site and immediately after the
collection of a blood unit, an additional 5 mL of whole blood was collected into a tube with eth-
ylenediaminetetraacetic acid (EDTA) and another 5 mL was collected into a serum separator
tube via the accessory port. Samples were stored at −20°C until analysis at the University of
Campinas and subsequently at Western University of Health Sciences. An overview of the diag-
nostic procedures performed in this study is presented in the Fig. 1.
Blood culture
Culture procedures used in this study followed the previous description by Duncan et al. [11]
and Maggi et al. [8], with modifications. Two milliliters of whole EDTA blood from each sub-
ject were thawed and added into 8 mL of liquid Bartonella alpha-Proteobacteria growth medi-
um (BAPGM) [23], incubated at 37°C in 5% CO2, water-saturated atmosphere and
maintained with a constant shaking motion for 14 days. Blood donor sample cultures were ma-
nipulated in batches of 75 flasks. A negative control flask containing only BAPGMmedium
was added to each batch of samples tested and subjected to the same laboratory procedures
and culture conditions. Subsequently, 1 mL of the blood-inoculated liquid culture was sub-in-
oculated onto agar enriched slant tubes containing 30% Bartonella spp.-negative sheep blood
(confirmed by PCR and culture methods) [24] for additional 42 days. BAPGM-negative con-
trols were also subcultured onto blood-agar. The agar slant tubes were inspected weekly for evi-
dence of bacterial growth. Because blood cultures in BAPGMmay yield other species of alpha-
Proteobacteria [25], an initial screening process was performed as demonstrated in Fig. 1.
Bartonella spp. Bacteremia in Blood Donors
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Colonies were Gram-stained and those isolates with suggestive morphology were suspended
and frozen in Brain and Heart Infusion (BHI) for future identification by DNA amplification
and sequencing. All Bartonella spp. culture methods were carried out in a class 2 biosafety cabi-
net in order to minimize the possibility of specimen contamination and to protect
laboratory personnel.
Bartonella genus PCR screening
Molecular techniques were performed in four separate rooms to avoid DNA contamination. A
uni-directional workflow was strictly enforced between pre-PCR areas (sample handling, PCR
set up, DNA extraction) and post-PCR areas (DNA amplification, gel analysis, and amplicon
Figure 1. Flowchart of the culture and PCR-based procedures performed to determineBartonella prevalence in 500 blood donors from Campinas,
Brazil.
doi:10.1371/journal.pntd.0003467.g001
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purification). Dedicated sets of equipment, pipettes, and supplies were used in each of these lo-
cations. Strict laboratory procedures were implemented in order to avoid potential contamina-
tion of reagents and samples with amplicons. In order to prevent PCR contamination, different
negative controls testing the different stages in the PCR process was included in every experi-
ment as described in the S1 Appendix.
After a 14-day incubation period, a 1 mL aliquot of liquid culture medium was centrifuged
and the pellet was subjected to DNA extraction using the QIAamp1 DNAMini Kit (QIAGEN
Inc., Valencia, CA). The average of DNA yield obtained was 6.19 ng/ul (SD: 32.8 ng/ul), and
the average 260/280 ratio was 1.47 (SD: 2.03). Screening of the 500 liquid culture samples was
performed using Bartonella genus-specific single tube PCR. This assay was manually designed
to target a hypervariable region of the 16S-23S rRNA gene intergenic transcribed spacer (ITS)
of Bartonella species using primers and conditions described in the S1 Appendix. For all PCR
reactions three controls were incorporated: negative BAPGM control (BAPGMmedium with
no blood inoculate and incubated simultaneously with each batch of liquid cultures), Master-
mix reagent control, and a positive control (DNA extracted from a Houston 1-ITS strain of B.
henselae; ATCC 49882). These screening tests were performed at the Multidisciplinary Center
of Biological Investigation (CEMIB), UNICAMP, Brazil.
Bartonella species identification
DNA obtained from Bartonella sp. positive liquid cultures and DNA from suspected subculture
isolates were retested at Western University of Health Sciences, USA, for species identification.
These DNA samples were tested by a Real-Time ITS PCR using primers manually designed to
amplify a fragment of the 16S-23S rRNA ITS region of all Bartonella species. PCR primers and
conditions are described in the S1 Appendix.
DNA samples from six isolates that were confirmed to contain Bartonella sp. DNA were fur-
ther characterized using previously published conventional PCR assays for the ITS region [26],
for the citrate synthase gene (gltA) [27], and the heme-binding phage-associated protein
(pap31) gene [26]. In addition, each sample was also tested using a specific conventional PCR
for Bartonella koehlerae [28]. DNA samples from liquid cultures were not tested by these assays
due to insufficient genomic material. Amplicons generated from any one of the five PCR assays
used during the confirmatory steps (Fig. 1) were sequenced for bacterial species identification
(S1 Appendix).
Serology
Using B. henselae and B. quintana antigens supplied by the Centers for Disease Control
and Prevention (CDC-Atlanta, USA), serum samples were analyzed for IgG antibodies to
B. henselae and B. quintana antigens by an indirect immunofluorescence assay (IFA) as
described in the S1 Appendix. Sera samples were tested at a 1:64 dilution. A positive test was
warranted if brightly stained bacteria could be detected by fluorescence microscopy at
400× magnification. Previously IFA negative serum samples were used as negative controls.
Data analysis
Subjects with positive ITS PCR results from isolates were considered bacteremic. Subjects posi-
tive from liquid culture were considered with Bartonella sp. bloodstream infection. Molecular
and serologic prevalence of Bartonella spp. were described as absolute frequencies, percentages,
and 95% confidence intervals (computed using score method) using JMP Pro 10 for Windows
(SAS Institute Inc., Cary, NC).
Bartonella spp. Bacteremia in Blood Donors
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Results
From the 500 blood donors tested, 16 (3.2%, 95% Confidence Interval [CI]: 2.0%–5.1%) sub-
jects were infected with a Bartonella spp. based on culture in liquid and/or isolation on solid
media followed by ITS Real-Time and/or conventional PCR in two different laboratories. ITS
amplicon sequence analysis revealed B. henselae in 15 of the 16 cultures (3%, 95% CI: 1.8%–
4.9%), and B. clarridgeiae in one culture (0.2%, 95% CI: 0%–1.1%) (Table 1). Among the 16
Bartonella sp. bloodstream-infected donors, 11 were confirmed by liquid culture followed by
PCR amplifications and DNA sequencing, whereas six bacteremic individuals were confirmed
after subculture onto blood slant tubes followed by PCR and DNA sequence confirmation
(Table 1). Only one subject was PCR positive in both liquid and solid subcultures.
When subsequently amplified and sequenced, four of these six isolates contained a larger
ITS region fragment (559 bp in size) that was 100% similar to B. henselae sequences deposited
in GenBank (accession number NC_005956.1). From one liquid culture sample, a 190 bp ITS
DNA sequence was obtained, being 100% similar to B. clarridgeiae (accession number
NC_014932.1). Similarly, the presence of B. henselae DNA was confirmed in five isolates by
also amplifying and sequencing the gltA gene (338 bp, 100% similarity to accession number
BX897699.1), and from three by amplification and sequencing of the pap31 gene (501 bp,
100% similarity to accession number DQ529248.1). By testing the isolates, no blood donor was
B. koehlerae PCR positive using species-specific ITS primers. The methodologies applied in our
Table 1. Serology and DNA sequencing results of 16 blood donors tested for exposure or infection with Bartonella species.
Blood donor Serology (IFA)a Bartonella species identified by DNA sequencing
B. henselae B. quintana Sample tested ITSb 314s-382as ITSb 325s-1100as Pap31c 1s-668as gltAd 781p-1137n
1 Negative Negative Liquid culture B. henselae NPe NP NP
2 Negative Negative Liquid culture/isolate B. henselaef B. henselae Negative Negative
3 Negative Negative Isolate B. henselae Negative Positiveg B. henselae
4 Positive Negative Liquid culture B. henselae NP NP NP
5 Negative Negative Isolate B. henselae B. henselae B. henselae B. henselae
6 Negative Negative Isolate B. henselae Negative Negative B. henselae
7 Negative Negative Isolate B. henselae B. henselae B. henselae B. henselae
8 Negative Negative Liquid culture B. henselae NP NP NP
9 Negative Negative Liquid culture B. henselae NP NP NP
10 Negative Negative Liquid culture B. clarridgeiae NP NP NP
11 Negative Negative Liquid culture B. henselae NP NP NP
12 Negative Negative Liquid culture B. henselae NP NP NP
13 Negative Negative Liquid culture B. henselae NP NP NP
14 Negative Positive Liquid culture B. henselae NP NP NP
15 Negative Negative Liquid culture B. henselae NP NP NP
16 Positive Positive Isolate B. henselae B. henselae B. henselae B. henselae
a Indirect immunofluorescence assay with cut-off of 1:64.
b 16S-23S rRNA gene intergenic transcribed spacer
c Heme-binding phage-associated protein
d Citrate synthase gene
e Not performed due to insufficient genomic material
f Both liquid culture and isolate yield the same Bartonella species. Other PCR assays were only performed on isolate due to insufficient genomic material
from liquid culture.
g A DNA sequence was not obtained for this sample.
doi:10.1371/journal.pntd.0003467.t001
Bartonella spp. Bacteremia in Blood Donors
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003467 January 15, 2015 6 / 12
laboratory allowed the isolation of fastidious bacteria morphologically similar to Bartonella by
Gram stain from 34 blood donors, with six isolates confirmed as Bartonella spp. by DNA se-
quencing. Some of the possible genera of the other isolates obtained in this study include
Arthrobacter, Bacillus, Dermabacter, Methylobacterium, Propionibacterium, Pseudomonas,
Sphingomonas, Staphylococcus and unknown “non-cultured” bacteria, as previously reported
by Cadenas et al. using the same liquid enrichment culture method [25].
Of the 500 blood donors tested, antibodies against B. henselae or B. quintana were detected
in 16.2% (81/500, 95% CI: 13.2%–19.7%) and 32% (160/500, 95% CI: 28.0%–36.2%), respec-
tively. Seropositivity for both antigens was detected in 13.4% of blood donors (67/500, 95% CI:
10.6%–16.7%). B. quintana DNA was not detected in any blood donor in this study. Only two
of the B. henselae seroreactive blood donors were confirmed by liquid culture/PCR as infected
with B. henselae. However, two B. quintana seroreactive donors had confirmed B. henselae
bloodstream infection, one of whom was also seroreactive to B. henselae. The B. clarridgeiae
bacteremic subject was seronegative to both Bartonella spp. antigens (Table 1).
Discussion
Using a combination of liquid and solid cultures, PCR, DNA sequencing, and serology, this
study documented the presence of Bartonella spp. bloodstream infections in 16 (3.2%) of 500
healthy blood donors presented to a major blood bank in Southeastern Brazil. Despite the fact
that exposure of blood donors to Bartonella spp. has been previously documented by serology
methods [29,30], no previous study has confirmed the presence of Bartonella spp. in blood do-
nors using similar culture and molecular diagnostic methods. A total of six B. henselae isolates
were obtained in this study, with other ten blood donors having blood infection with B. henselae
or B. clarridgeiae identified by liquid culture enrichment coupled with DNA amplification by
PCR at two different laboratories. These results indicate, for the first time, that asymptomatic
blood donors can be infected with Bartonella spp. at the time of blood donation.
Bartonella spp. are re-emerging infectious agents that can induce asymptomatic and intraer-
ythrocytic infection in preferred and accidental hosts. These bacteria have been isolated from
both immunocompetent and immunodeficient human patients [8,9,31]. Any asymptomatic in-
fection with a blood-borne pathogen has the potential for transfusion transmission. The surviv-
al of B. henselae in collected human blood units [12] associated with the bacterium’s ability to
cause infection by the intravenous route as described in animal models [14,32], and in humans
after needle stick accidents [15,16], supports a potential risk for transmission through blood
transfusions. Although well-documented human cases of blood transfusion transmission have
not yet been published, our data further support the hypothesis that this can occur.
Transmission via blood transfusion is of great relevance if the transfused agent subsequently
causes short or long-term disease manifestation in the donor recipient. In humans, cat-scratch
fever, bacillary angiomatosis and endocarditis are the most common historically recognized
disease entities caused by Bartonella sp. infection [1]. However, non-specific symptoms have
been described, including fever of unknown origin, local or generalized lymphadenopathy, se-
vere or recurrent anemia, chronic uveitis, optic neuritis, frequent headaches, fatigue, intermit-
tent paresthesias, and granulomatous or angioproliferative reactions of undefined etiologies
[15,16,33,34]. Similar non-specific clinical signs have been reported in Bartonella sp. bacter-
emic cats and dogs [35–37].
Diagnosis of bartonellosis remains a microbiological challenge because of the difficulty of
culturing and isolating the bacterium from patient specimens. Bartonella sp. is highly fastidious
and isolation by direct plating of blood or other clinical samples is not always successful. In
order to improve the chances of isolation of Bartonella sp. from blood, samples should be
Bartonella spp. Bacteremia in Blood Donors
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cultured in liquid enrichment media to support growth [11], similar to culture techniques used
for Haemophilus influenza and other bacteria species [38]. In our study, Bartonella spp. DNA
was identified more frequently from BAPGM liquid culture samples than from subculture iso-
lates, with only one subject PCR positive at both culture methods (Table 1). Similar discrepan-
cies between results from liquid and solid culture methods were previously documented.
Among 122 Bartonella-infected patients in the USA, 48 (39%) had BAPGM liquid culture sam-
ples positive for Bartonella DNA, but isolates were obtained only from five subjects (4%), in-
cluding from two patients with PCR-negative liquid culture samples [4]. Causes for these
differences are not completely elucidated and may be associated with low levels of bacteremia
in asymptomatic humans [1]. In this study, the amount of viable Bartonella spp. in the blood-
stream of these infected blood donors was not determined. Low bacterial burden in the blood-
stream may limit the transmission of Bartonella spp. to a blood recipient or the development of
infection. In addition, the discrepancy between the number of Bartonella sp. isolates obtained
and the number of BAPGM samples positive by PCR could indicate that PCR-positive
BAPGM samples contained non-viable bacteria. However, the two culture systems used in this
study were designed to reproduce the vector environment (insect-based liquid culture medium
BAPGM) and the host environment (blood-enriched agar medium), and each culture system
may have facilitated the growth and detection of specific wild types of Bartonella. Consequent-
ly, the use of a combined diagnostic platform for testing the presence of Bartonella spp. DNA
in BAPGM liquid culture and in subculture isolates in this study provided enhanced sensitivity,
as previously demonstrated [39].
Evidence of Bartonella sp. infection may be confirmed by microbiological isolation, molecu-
lar techniques, and histopathologic visualization of Bartonella sp. antigens from tissue samples.
Serology can be used to document exposure, but does not confirm infection. In this study, anti-
bodies against B. quintana or B. henselae were detected in 32% (136/500) and 16.2% (78/500),
respectively. A previous Brazilian study involving 437 healthy subjects from a rural area of
Minas Gerais state documented B. quintana and B. henselae seroprevalences of 12.8% and
13.7%, respectively [40]. In Sweden, overall Bartonella spp. seroprevalence among 498 blood
donors was 16.1%, but only 1.2% of those subjects were seropositive for B. henselae [29]. In
New Zealand, 5% of 140 blood donors were seropositive for B. henselae [30]. In our study, anti-
bodies against Bartonella sp. correlated poorly with infection as detected by PCR amplification
followed by DNA sequencing or with the successful isolation of Bartonella organisms. Similar
findings have been previously demonstrated in animals [14,41] and human patients [4,8], even
in individuals with symptomatic disease [8,42]. Difficulties in Bartonella serodiagnosis are ex-
emplified in the study by Vermeulen et al. [42]. It is suggested that Bartonella spp. manipulate
the host immune system on a systemic scale to achieve a state of immunological attenuation,
including stimulation of IL-10 secretion, which suppresses the capabilities of various immune
cells, including T helper cells, monocytes/macrophages, and dendritic cells, thus interfering
with both innate and adaptive immune responses [9,10]. Therefore, our results indicate that
the predictive value of serology to detect Bartonella spp. infection in asymptomatic donors is
low, supporting the recommendation that antibody status should not be used as a sole diagnos-
tic modality to determine Bartonella spp. infection in blood donors. Moreover, negative results
in one or more currently available diagnostic tests cannot exclude infection and, whenever pos-
sible, a combination of diagnostic tests is encouraged [42,43].
Another factor related to the apparent emergence of Bartonella spp. is the development of
diagnostic techniques with improved sensitivity [4]. In recent years, the development of more
sensitive and specific PCR methods, coupled with enrichment growth in specific culture media,
has increased the detection of this pathogen in animal and human patient samples [4,8,11,26].
It is of clinical and epidemiological relevance that failure to amplify Bartonella sp. gene targets,
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following extraction of DNA from patient blood samples, does not rule out this bloodstream
infection. It is estimated that Bartonella bacteremia in asymptomatic donors is approximately
10 CFU/mL of blood [1], which may be below the detection limit of most conventional or
Real- Time PCR assays. Another reason for false-negative PCR or culture results is that Barto-
nella spp. typically cause a cyclic bacteremia [9]. It has been recently demonstrated that the de-
tection of Bartonella sp. infection in humans is improved when three sequential blood samples
are tested during a one-week period [39]. In that study, only 3 of 12 patients with Bartonella
sp. bloodstream infection were documented as positive on more than one sample test date and
no patient was positive on liquid culture/PCR for all three specimen test dates. Therefore, the
number of bacteremic subjects may be underestimated in our study because only one blood
sample from each blood donor was tested. We hypothesize that the actual number of blood do-
nors infected with a Bartonella spp. may be higher in healthy humans than our current findings
have documented. The low bacterial levels and the cyclic feature of Bartonella sp. bloodstream
infection reinforce this hypothesis [9,10].
Based on recommendations by the Ethics Committee from UNICAMPMedical School,
Bartonella sp. positive blood donors in this study were considered inappropriate for further
blood donations. To the authors’ knowledge, there are no specific guidelines in the USA or
other countries designed to prevent transfusion of human blood when donors are suspected to
be infected with a Bartonella species. In Veterinary Medicine, at least two major medical boards
have issued recommendations regarding blood donors. In 2005, the American College of Vet-
erinary Internal Medicine (ACVIM) conditionally recommended the screening of canine and
feline blood donors in order to obtain a Bartonella-free donor pool, especially for cats due to
the high frequency of bacteremia in this host [44]. This recommendation for cats has been re-
cently ratified by the European Advisory Board on Cat Diseases (ABCD) [45]. The results of
our study indicate that guidelines for human blood transfusions should be designed, with spe-
cial attention to the selection of Bartonella-free blood products for transfusion to immune sup-
pressed subjects, which would include pediatric and geriatric patients.
The results of this study indicate that human exposure to Bartonella spp. frequently occurs
in the Southeast region of Brazil, and that Bartonella sp. bacteremia occurs in asymptomatic
blood donors. There is a risk of blood supply contamination with these pathogens from asymp-
tomatic bacteremic donors. The impact of transmission of Bartonella spp. through blood trans-
fusions recipients should be evaluated, as well as the use of advanced diagnostic techniques for
the screening of Bartonella sp. infection among blood donors.
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